Company intelligence / Profile preview

Versono Medical

Ownership: Private
Development stage: Preclinical

Overview

Versono Medical is developing a novel intravascular ultrasonic device platform to cross, prepare, and support endovascular therapy for complex chronic and acute vascular occlusions. The technology aims to improve outcomes in patients with critical limb threatening ischemia by enabling minimally invasive procedures that reduce the need for amputation. The company is still early stage; no published clinical results yet.

Therapeutic areas: Cardiovascular
Modalities: DeviceIntravascular ultrasonic system (Device)
Industry: Surgical Medical Devices

Partnerships

Collaborations with clinicians and research institutions worldwide

Beyond the preview

Go deeper on Versono Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Versono Medical.

Explore the full profile